Part II of the consensus guidelines updates the recommendations for the periprocedural
management of thrombotic and bleeding risks in patients who require image-guided …

A higher risk of thrombosis has been described as a prominent feature of coronavirus
disease 2019 (COVID-19). This systematic review synthesizes current data on thrombosis …

Atrial fibrillation (AF) confers a substantial risk of mortality and morbidity from stroke and
thrombo-embolism, and this common cardiac arrhythmia represents a major healthcare …

When patients receiving anticoagulation therapy undergo invasive procedures,
management requires an individualized assessment of the risk of bleeding versus the risk of …

In patients with atrial fibrillation (AF) who require interruption of dabigatran or warfarin for an
elective surgery/procedure, the risks and benefits of perioperative bridging anticoagulation …

Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in
mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050 …

The periprocedural management of patients receiving chronic therapy with oral
anticoagulants (OACs), including vitamin K antagonists (VKAs) such as warfarin and direct …

Abstract Abbreviations and Acronyms: DOACs: direct oral anticoagulants; INR: international
normalized ratio; LMWH: low molecular weight heparin; PAD: peripheral artery disease; …

Chronic oral anticoagulation frequently requires interruption for various reasons and
durations. Whether or not to bridge with heparin or other anticoagulants is a common clinical …

Direct oral anticoagulants (DOACs) have been licensed worldwide for several years for
various indications. Each year, 10–15% of patients on oral anticoagulants will undergo an …